Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1988 Sep;32(9):1435–1436. doi: 10.1128/aac.32.9.1435

In vitro activities of the newer beta-lactam and quinolone antimicrobial agents against Pseudomonas pseudomallei.

L R Ashdown 1
PMCID: PMC175884  PMID: 3196005

Abstract

Imipenem was highly active and bactericidal against all 100 strains of Pseudomonas pseudomallei tested, followed in activity by piperacillin, carumonam, ceftazidime, cefotaxime, and ceftriaxone. The addition of clavulanic acid significantly increased the activities of both amoxicillin and ticarcillin. Ciprofloxacin and norfloxacin showed poor activity against test strains.

Full text

PDF
1435

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ashdown L. R., Duffy V. A., Douglas R. A. Meliodosis. Med J Aust. 1980 Apr 5;1(7):314–316. [PubMed] [Google Scholar]
  2. Ashdown L. R., Frettingham R. J. In vitro activity of various cephalosporins against Pseudomonas pseudomallei. J Infect Dis. 1984 Nov;150(5):779–780. doi: 10.1093/infdis/150.5.779. [DOI] [PubMed] [Google Scholar]
  3. Ashdown L. R. Identification of Pseudomonas pseudomallei in the clinical laboratory. J Clin Pathol. 1979 May;32(5):500–504. doi: 10.1136/jcp.32.5.500. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chau P. Y., Ng W. S., Leung Y. K., Lolekha S. In vitro susceptibility of strains of Pseudomonas pseudomallei isolated in Thailand and Hong Kong to some newer beta-lactam antibiotics and quinolone derivatives. J Infect Dis. 1986 Jan;153(1):167–170. doi: 10.1093/infdis/153.1.167. [DOI] [PubMed] [Google Scholar]
  5. Cheong Y. M., Joseph P. G., Koay A. S. In-vitro susceptibility of Pseudomonas pseudomallei isolated in Malaysia to some new cephalosporins and a quinolone. Southeast Asian J Trop Med Public Health. 1987 Mar;18(1):94–96. [PubMed] [Google Scholar]
  6. Guard R. W., Khafagi F. A., Brigden M. C., Ashdown L. R. Melioidosis in Far North Queensland. A clinical and epidemiological review of twenty cases. Am J Trop Med Hyg. 1984 May;33(3):467–473. doi: 10.4269/ajtmh.1984.33.467. [DOI] [PubMed] [Google Scholar]
  7. Howe C., Sampath A., Spotnitz M. The pseudomallei group: a review. J Infect Dis. 1971 Dec;124(6):598–606. doi: 10.1093/infdis/124.6.598. [DOI] [PubMed] [Google Scholar]
  8. Rode J. W., Webling D. D. Melioidosis in the Northern Territory of Australia. Med J Aust. 1981 Feb 21;1(4):181–184. doi: 10.5694/j.1326-5377.1981.tb135443.x. [DOI] [PubMed] [Google Scholar]
  9. So S. Y., Chau P. Y., Leung Y. K., Lam W. K., Yu D. Y. Successful treatment of melioidosis caused by a multiresistant strain in an immunocompromised host with third generation cephalosporins. Am Rev Respir Dis. 1983 May;127(5):650–654. doi: 10.1164/arrd.1983.127.5.650. [DOI] [PubMed] [Google Scholar]
  10. Wilson J. W., Ashdown L. R., Richards M. J., Sutherland A. D., Cade J. F. Subacute pulmonary melioidosis in a temperate climate. Med J Aust. 1987 Jul 20;147(2):95–96. doi: 10.5694/j.1326-5377.1987.tb133271.x. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES